Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is May 23, 2024.
All times in Eastern Daylight Time.
-
Pei enters the MSCI COLCAP indexBOGOTA, Colombia--(BUSINESS WIRE)--Pei, the leading real estate investment trust in Colombia, has been selected to be part of the MSCI COLCAP, a stock index that tracks the performance of the 20 mo... more »
-
Oklo Partners with Wyoming Hyperscale to Deliver 100 Megawatts to its Data CentersSANTA CLARA, Calif.--(BUSINESS WIRE)--Oklo Inc. (NYSE: OKLO) (“Oklo”), a fast fission clean power technology and nuclear fuel recycling company, announced its collaboration with Wyoming Hyperscale ... more »
-
NW Natural Holdings and NW Natural CEO David H. Anderson Announces RetirementPORTLAND, Ore.--(BUSINESS WIRE)--NW Natural Holding Company (NYSE: NWN) (NW Natural Holdings) and NW Natural Gas Company (NW Natural) chief executive officer (CEO) David H. Anderson announced today... more »
-
Flatiron Health Announces Research to Be Presented at American Society of Clinical Oncology 2024 Annual MeetingNEW YORK--(BUSINESS WIRE)--Flatiron Health today announced its significant presence at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting, to be held in Chicago this June. Nine... more »
-
Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual MeetingLOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology announced that two abstracts for its drug Alisertib to be presented at the 2024 ASCO Annual Meeting are now posted on ASCO.org. more »
-
Nimbus Therapeutics Presents New Positive Monotherapy Phase 1/2 Clinical Data of HPK1 Inhibitor in Treatment of Advanced Solid Tumors at 2024 ASCO Annual MeetingBOSTON--(BUSINESS WIRE)--Nimbus Therapeutics, LLC (“Nimbus Therapeutics” or “Nimbus”), a biotechnology company that designs and develops breakthrough medicines for patients through its powerful com... more »
-
Barnes & Noble Education Announces Preliminary Fiscal Year 2024 ResultsBASKING RIDGE, N.J.--(BUSINESS WIRE)--Barnes & Noble Education, Inc. (NYSE: BNED) (“BNED” or the “Company”), a leading solutions provider for the education industry, today announced certain pre... more »
-
Breakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual MeetingLEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced a novel analysis from the Phase... more »
-
OKLAHOMA CITY--(BUSINESS WIRE)--Federman & Sherwood Investigates Association of California School Administrators for Data Breach more »
-
Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research PlatformsPRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications.... more »
-
Aulos Bioscience Provides Positive Interim Phase 1/2 Data From AU-007 at 2024 ASCO Annual MeetingLARKSPUR, Calif.--(BUSINESS WIRE)--Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of best-in-class IL-2 therapeutics, today shared interim... more »
-
TelevisaUnivision Announces Pricing of $1.0 Billion DebtNEW YORK--(BUSINESS WIRE)--TelevisaUnivision, Inc. today announced that its wholly-owned subsidiary, Univision Communications Inc. (the “Company”), has priced its refinancing of $1.0 billion of deb... more »
-
TIGER Study Reports New TTFields Therapy Survival Results for Newly Diagnosed Glioblastoma Patients in GermanyROOT, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) today released topline efficacy and safety data from the TIGER study investigating the use of Tumor Treating Fields (TTFields) therapy in... more »
-
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bi... more »
-
BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. Declares DistributionNEW YORK--(BUSINESS WIRE)--On May 23, 2024, BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. (Ticker: XALCX) declared a distribution of $2.00 per share of common stock, payable on June 2... more »